Medicamen Organics IPO Subscription Status, Rate

Medicamen Organics IPO Allotment Status Online

Medicamen Organics IPO Subscription Status: Medicamen Organics IPO is Open on 21 June, 2024 and Close on 25 June, 2024. Medicamen Organics IPO to Raise 3,100,000 shares (Approx ₹10.54 Cr) via IPO. The Fresh Issue of 3,100,000 shares (Approx ₹10.54 Cr).

  • The Retail Quota is 35%
  • QIB is 50%
  • NII is 15%

Medicamen Organics IPO is an SME IPO and Listed on NSE SME. Medicamen Organics IPO Price Band is Fixed at ₹34 Equity Share. Medicamen Organics IPO Lot Size is 4000 Shares.

About Medicamen Organics IPO :

  • Medicamen Organics are engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer.
  • We market our product to private pharma companies in domestic as well as international markets through third party distributors or on loan license basis. We have a track record of operating B2B model which covers contract manufacturing model.

Medicamen Organics IPO Subscription Status, Rate bid times

Inv Category Shares Reserved No. of Shares bid for No. of Times (Subscription)
Qualified Buyers (QIBs) 5,84,000 10,10,52,000 173.03
Non Institutional Buyers (NIIs) 4,40,000 59,12,84,000 1343.83
Retail Individual Buyers (RIIs) 10,28,000 1,34,64,44,000 1309.77
Anchor Investor 8,76,000 8,76,000 1
Total 20,52,000 2,03,87,80,000 993.56

Medicamen Organics Subscription Status day-by-day-

Categories 21 June 24 June 25 June
QIB 1.01 1.42 173.03
NII 35.77 123.71 1343.83
RII 85.96 336.32 1309.77
Total 51.03 195.42 993.56

Medicamen Organics Investor Categories

  • Qualified Institutional Buyers (QIB).
  • Non- Institutional Investors (NII).
  • Retail individual Investors (RII).
  • Employee (EMP).
  • Others (Eligible Shareholders).

Who Is QIB In IPO?

QIB Stands For “Qualified Institutional Buyer” In The Context Of An IPO (Initial Public Offering). QIBs Are A Category Of Institutional Investors Who Are Considered Financially Sophisticated And Meet Certain Regulatory Criteria For Participating In Capital Markets. In The Context Of An IPO, QIBs Play A Significant Role As They Contribute To The Overall Demand For Shares And Help Determine The Success Of The Offering.

Who Is NII In IPO?

NII Stands For “Non-Institutional Investors” In The Context Of An IPO (Initial Public Offering). Non-Institutional Investors Are A Category Of Investors Who Participate In The IPO Alongside Institutional Investors And Retail Investors. NII Typically Includes High Net Worth Individuals (HNIs), Corporate Bodies, Trusts, And Other Entities That Are Not Classified As Institutional Investors But Have The Financial Capacity To Invest Significant Amounts In The IPO.

Who Is RII In IPO?

RII Stands For “Retail Individual Investor” In The Context Of An IPO (Initial Public Offering). Retail Individual Investors Are Individual Investors Who Participate In The IPO Alongside Institutional Investors And Non-Institutional Investors. RII Typically Includes Individual Investors Who Do Not Meet The Criteria To Be Classified As Institutional Investors Or Non-Institutional Investors.

Who Is EMP In IPO?

“EMP” In The Context Of An IPO (Initial Public Offering) Typically Stands For “Employee.” In Some IPOs, A Certain Portion Of The Shares May Be Reserved For Allocation To Employees Of The Company Going Public. These Employees Are Often Referred To As “Employee Shareholders” Or “Employee Participants” (EMP).

Medicamen Organics Review From MoneyMintIdea –

  • May Apply

Leave a Comment

Facebook
Twitter
WhatsApp
Telegram
LinkedIn